Send E-mail
  • Daewha Pharma receives US$20m order from NovoSci in UAE
    Daewha Pharma receives US$20m order from NovoSci in UAE
    Daewha Pharmaceutical (067080) reported on Oct. 12 that it has inked a US$20.12 million five-year contract with NovoSci in United Arab Emirates to supply pharmaceutical products under the condition its products are granted approval for sale in 11 countries including Saudi Arabia. This amounts to 16.16 percent of its revenue last year.By Yun Jeong-hyeon (clareyun@heraldcorp.com)
From
Send to
Close Send

Daewha Pharma receives US$20m order from NovoSci in UAE

Oct. 12, 2016 - 15:49 By 윤정현
[DISCLOSURE] Daewha Pharmaceutical (067080) reported on Oct. 12 that it has inked a US$20.12 million five-year contract with NovoSci in United Arab Emirates to supply pharmaceutical products under the condition its products are granted approval for sale in 11 countries including Saudi Arabia. 

This amounts to 16.16 percent of its revenue last year.

By Yun Jeong-hyeon (clareyun@heraldcorp.com)
Most Popular